Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D 4 receptor activation

Brain Research

Volumn 1407, Issue , 2011, Pages 47-61

  Gago, Belén ^a   Suárez Boomgaard, Diana ^a   Fuxe, Kjell ^b   Brené, Stefan ^c   Reina Sánchez, María Dolores ^a   Rodríguez Pérez, Luis M ^a   Agnati, Luigi F ^d   De La Calle, Adelaida ^a   Rivera, Alicia ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d IRCCS SAN CAMILLO HOSPITAL   (Italy)

Author keywords

Opioid receptor; D 4R agonist; Morphine; Receptor receptor interaction; Transcription factor

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 4 RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; N [4 (2 CYANOPHENYL) 1 PIPERAZINYLMETHYL] 3 METHYLBENZAMIDE; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DELTA FOSB; TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG DEPENDENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; STRIATE CORTEX;

ANALGESICS, OPIOID; ANIMALS; AUTORADIOGRAPHY; BENZAMIDES; CAUDATE NUCLEUS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; GENES, FOS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MORPHINE; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-FOS; PUTAMEN; PYRIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D4; TRANSCRIPTION FACTORS;

RATTUS;

EID: 79960979418     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.06.046     Document Type: Article

References (71)

1. Ambrose, L.M., Unterwald, E.M., Van Bockstaele, E.J., 2004. Ultrastructural evidence for co-localization of dopamine D2 and micro-opioid receptors in the rat dorsolateral striatum. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 279, 583-591.
2. Ariano, M.A., Wang, J., Noblett, K.L., Larson, E.R., Sibley, D.R., 1997. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res. 752, 26-34. (Pubitemid 27143894)
3. Arvidsson, U., Riedl, M., Chakrabarti, S., Lee, J.H., Nakano, A.H., Dado, R.J., Loh, H.H., Law, P.Y., Wessendorf, M.W., Elde, R., 1995. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15, 3328-3341.
4. Bilecki, W., Wawrzczak-Bargiela, A., Przewlocki, R., 2004. Activation of AP-1 and CRE-dependent gene expression via μ-opioid receptor. J. Neurochem. 90, 874-882. (Pubitemid 39099969)
5. Bontempi, B., Sharp, F.R., 1997. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J. Neurosci. 17, 8596-8612. (Pubitemid 27461080)
6. Borroto-Escuela, D., Ciruela, F., Van Craenenbroeck, K., Romero-Fernandez, W., Gómez-Soler, M., Guidolin, D., Woods, A., Rivera, A., Haegeman, G., Agnati, L.F., Tarakanov, A.O., Fuxe, K., 2011. Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions. Biochem. Biophys. Res. Commun. 404, 928-934.
7. Canales, J.J., 2005. Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol. Learn. Mem. 83, 93-103.
8. Chang, S.L., Squinto, S.P., Harlan, R.E., 1988. Morphine activation of c-fos expression in rat brain. Biochem. Biophys. Res. Commun. 157, 698-704.
9. Cook, D.F., Wirtshafter, D., 1998. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists. Eur. J. Pharmacol. 349, 41-47.
10. Curran, T., Gordon, M.B., Rubino, K.L., Sambucetti, L.C., 1987. Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2, 79-84. (Pubitemid 18021075)
11. Di Chiara, G., Imperato, A., 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 85, 5274-5278.
12. Dulawa, S.C., Grandy, D.K., Low, M.J., Paulus, M.P., Geyer, M.A., 1999. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci. 19, 9550-9556. (Pubitemid 30228106)
13. Ebstein, R.P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E.R., Nemanov, L., Katz, M., Belmaker, R.H., 1996. Dopamine D4 receptor (D4DR) exon III polymorphismassociated with the human personality trait of novelty seeking. Nat. Genet. 12, 78-80.
14. Everitt, B.J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J.W., Robbins, T.W., 2008. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans. R. Soc. Lond. B. Biol. Sci. 363, 3125-3335.
15. Fasano, S., Pittenger, C., Brambilla, R., 2009. Inhibition of CREB activity in the dorsal portion of the striatum potentiates behavioral responses to drugs of abuse. Front. Behav. Neurosci. 3, 1-10.
16. Ferguson, S.M., Thomas, M.J., Robinson, T.E., 2004. Morphine-induced c-fos mRNA expression in striatofugal circuits: modulation by dose, environmental context, and drug history. Neuropsychopharmacology 29, 1664-1674. (Pubitemid 39150108)
17. Fossum, E.N., Lisowski, M.J., Macey, T.A., Ingram, S.L., Morgan, M.M., 2008. Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception. Brain Res. 1204, 53-58.
18. Frankel, P.S., Harlan, R.E., Garcia, M.M., 1999. Chronic administration of morphine alters immediate-early gene expression in the forebrain of post-dependent rats. Brain Res. 835, 204-212. (Pubitemid 29343782)
19. Fuxe, K., Canals, M., Torvinen, M., Marcellino, D., Terasmaa, A., Genedani, S., Leo, G., Guidolin, D., Diaz-Cabiale, Z., Rivera, A., Lundstrom, L., Langel, U., Narvaez, J., Tanganelli, S., Lluis, C., Ferré, S., Woods, A., Franco, R., Agnati, L.F., 2007. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural. Transm. 114, 49-75.
20. Fuxe, K., Marcellino, D., Rivera, A., Diaz-Cabiale, Z., Filip, M., Gago, B., Roberts, D.C., Langel, U., Genedani, S., Ferraro, L., de la Calle, A., Narvaez, J., Tanganelli, S., Woods, A., Agnati, L.F., 2008. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58, 415-452.
21. Gago, B., Fuxe, K., Agnati, L., Penafiel, A., De La Calle, A., Rivera, A., 2007. Dopamine D(4) receptor activation decreases the expression of mu-opioid receptors in the rat striatum. J. Comp. Neurol. 502, 358-366.
22. Garcia, M.M., Brown, H.E., Harlan, R.E., 1995. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res. 692, 23-40.
23. Georges, F., Stinus, L., Le Moine, C., 2000. Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur. J. Neurosci. 12, 4475-4486.
24. Gerfen, C.R., Wilson, C.J., 1996. The basal ganglia. In: Swanson, L.W., Bjoérklund, A., Hoekfelt, T. (Eds.), Handbook of Chemical Neuroanatomy. Elsevier Science, Amsterdam, pp. 371-468.
25. Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma Jr., F.J., Sibley, D.R., 1990. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432. (Pubitemid 120031867)
26. Glase, S.A., Akunne, H.C., Georgic, L.M., Heffner, T.G., MacKenzie, R.G., Manley, P.J., Pugsley, T.A., Wise, L.D., 1997. Substituted [(4- phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists. J. Med. Chem. 40, 1771-1772.
27. Grande, C., Zhu, H., Martin, A.B., Lee, M., Ortiz, O., Hiroi, N., Moratalla, R., 2004. Chronic treatment with atypical neuroleptics induces striosomal FosB/DeltaFosB expression in rats. Biol. Psychiatry 55, 457-463. (Pubitemid 38338532)
28. Guitart, X., Thompson, M.A., Mirante, C.K., Greenberg, M.E., Nestler, E.J., 1992. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58, 1168-1171.
29. Härfstrand, A., Fuxe, K., Agnati, L., Fredholm, B., 1989. Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis. J. Neural Transm. 75, 83-99.
30. Hiroi, N., Graybiel, A.M., 1996. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol. 374, 70-83.
31. Hughes, P., Dragunow, M., 1995. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47, 133-178.
32. Johnson, S.W., North, R.A., 1992. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12, 483-488.
33. Juhasz, J.R., Hasbi, A., Rashid, A.J., So, C.H., George, S.R., O'Dowd, B.F., 2008. Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur. J. Pharmacol. 581, 235-243.
34. Khan, Z.U., Gutiérrez, A., Martín, R., Peñafiel, A., Rivera, A., De La Calle, A., 1998. Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J. Comp. Neurol. 402, 353-371.
35. Kulagowski, J.J., Broughton, H.B., Curtis, N.R., Mawer, I.M., Ridgill, M.P., Baker, R., Emms, F., Freedman, S.B., Marwood, R., Patel, S., Patel, S., Ragan, C.I., Leeson, P.D., 1996. 3-((4-(4-Chlorophenyl) piperazin-1-yl)-methyl)- 1Hpyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. J. Med. Chem. 39, 1941-1942.
36. Le Moine, C., Bloch, B., 1995. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355, 418-426.
37. Liu, J., Nickolenko, J., Sharp, F.R., 1994. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U. S. A. 91, 8537-8541.
38. MacGibbon, G.A., Lawlor, P.A., Bravo, R., Dragunow, M., 1994. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res. Mol. Brain Res. 23, 21-32.
39. Mansour, A., Fox, C.A., Burke, S., Akil, H., Watson, S.J., 1995. Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8, 283-305.
40. Matthes, H.W., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B.P., Kieffer, B.L., 1996. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383, 819-823.
41. Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., Caron, M.G., 1998. Dopamine receptors: from structure to function. Physiol. Rev. 78, 189-225.
42. Muller, D.L., Unterwald, E.M., 2005. D1dopamine receptorsmodulate deltaFosB induction in rat striatumafter intermittent morphine administration. J. Pharmacol. Exp. Ther. 314, 148-154.
43. Nestler, E.J., 2004a. Historical review: molecular and cellular mechanismsof opiate and cocaine addiction. Trends Pharmacol. Sci. 25, 210-218.
44. Nestler, E.J., 2004b. Molecular mechanisms of drug addiction. Neuropharmacology 47, 24-32. (Pubitemid 39298250)
45. Nestler, E.J., 2005. Is there a common molecular pathway for addiction? Nat. Neurosci. 8, 1445-1449. (Pubitemid 41573654)
46. Nestler, E.J., Kelz, M.B., Chen, J., 1999. DeltaFosB: a molecular mediator of long-term neural and behavioral plasticity. Brain Res. 835, 10-17. (Pubitemid 29336545)
47. Nye, H.E., Nestler, E.J., 1996. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49, 636-645.
48. Perrotti, L.I., Weaver, R.R., Robison, B., Renthal, W., Maze, I., Yazdani, S., Elmore, R.G., Knapp, D.J., Selley, D.E., Martin, B.R., Sim-Selley, L., Bachtell, R.K., Self, D.W., Nestler, E.J., 2008. Distinct patterns of DeltaFosB induction in brain by drugs of abuse. Synapse 62, 358-369. (Pubitemid 351451804)
49. Powell, S.B., Paulus, M.P., Hartman, D.S., Godel, T., Geyer, M.A., 2003. RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice. Neuropharmacology 44, 473-481. (Pubitemid 36293979)
50. Pozzi, L., Håkansson, K., Usiello, A., Borgkvist, A., Lindskog, M., Greengard, P., Fisone, G., 2003. Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J. Neurochem. 86, 451-459. (Pubitemid 36842444)
51. Rios, C., Gomes, I., Devi, L.A., 2006. Mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br. J. Pharmacol. 148, 387-395.
52. Rivera, A., Cuellar, B., Giron, F.J., Grandy, D.K., de la Calle, A., Moratalla, R., 2002. Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum. J. Neurochem. 80, 219-229. (Pubitemid 34809367)
53. Rivera, A., Trías, S., Peñafiel, A., Narváez, J.A., Díaz-Cabiale, Z., Moratalla, R., de la Calle, A., 2003. Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum. Brain Res. 989, 35-41. (Pubitemid 37281399)
54. Rivera, A., Peñafiel, A., Megías, M., Agnati, L.F., López-Téllez, J.F., Gago, B., Gutiérrez, A., de la Calle, A., Fuxe, K., 2008. Cellular localization and distribution of dopamine D(4) receptors in the rat cerebral cortex and their relationship with the cortical dopaminergic and noradrenergic nerve terminal networks. Neuroscience 155, 997-1010.
55. Robbins, M.J., Critchlow, H.M., Lloyd, A., Cilia, J., Clarke, J.D., Bond, B., Jones, D.N., Maycox, P.R., 2008. Differential expression of IEG mRNA in rat brain following acute treatment with clozapine or haloperidol: a semi-quantitative RT-PCR study. J. Psychopharmacol. 22, 536-542.
56. Robertson, G.S., Lee, C.J., Sridhar, K., Nakabeppu, Y., Cheng, M., Wang, Y.M., Caron, M.G., 2004. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors. Eur. J. Neurosci. 20, 3189-3194.
57. Rondou, P., Haegeman, G., Van Craenenbroeck, K., 2010. The dopamine D4 receptor: biochemical and signalling properties. Cell Mol. Life Sci. 67, 1971-1986.
58. Sebens, J.B., Koch, T., Ter Horst, G.J., Korf, J., 1995. Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment. Eur. J. Pharmacol. 273, 175-182.
59. Sharp, F.R., Liu, J., Nickolenko, J., Bontempi, B., 1995. NMDA and D1 receptors mediate induction of c-fos and junB genes in striatum following morphine administration: implications for studies of memory. Behav. Brain Res. 66, 225-230.
60. Stansfield, K.H., Kirstein, C.L., 2006. Effects of novelty on behavior in the adolescent and adult rat. Dev. Psychobiol. 48, 10-15.
61. Taracha, E., Lehner, M., Wisłowska-Stanek, A., Zienowicz, M., Maciejak, P., Bidziński, A., Skórzewska, A., Turzyńska, D., Płaźnik, A., 2006. Effects of methadone and morphine on c-Fos expression in the rat brain: similarities and differences. Pharmacol. Rep. 58, 120-124.
62. Van Craenenbroeck, K., Borroto-Escuela, D.O., Romero-Fernandez, W., Skieterska, K., Rondou, P., Lintermans, B., Vanhoenacker, P., Fuxe, K., Ciruela, F., Haegeman, G., 2011. Dopamine D4 receptor oligomerization-contribution to receptor biogenesis. FEBS J. 278, 1333-1344.
63. Vilardaga, J.P., Nikolaev, V.O., Lorenz, K., Ferrandon, S., Zhuang, Z., Lohse, M.J., 2008. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. Nat. Chem. Biol. 4, 126-131.
64. Wang, H., Pickel, V.M., 2001. Preferential cytoplasmic localization of delta-opioid receptors in rat striatal patches: comparison with plasmalemmal mu-opioid receptors. J. Neurosci. 21, 3242-3250. (Pubitemid 32323506)
65. Wang, H., Moriwaki, A.,Wang, J.B., Uhl, G.R., Pickel, V.M., 1996. Ultrastructural immunocytochemical localization ofmu opioid receptors and Leu5-enkephalin in the patch compartment of the rat caudate-putamen nucleus. J. Comp.Neurol. 375, 659-674. (Pubitemid 26398346)
66. Wang, H., Moriwaki, A., Wang, J.B., Uhl, G.R., Pickel, V.M., 1997. Ultrastructural immunocytochemical localization ofmu-opioid receptors in dendritic targets of dopaminergic terminals in the rat caudate-putamen nucleus. Neuroscience 81, 757-771. (Pubitemid 27402522)
67. Werme, M., Ringholm, A., Olson, L., Brené, S., 2000. Differential patterns of induction of NGFI-B, Nor1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res. 863, 112-119. (Pubitemid 30201590)
68. White, N.M., Hiroi, N., 1998. Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc. Natl. Acad. Sci. U. S. A. 95, 6486-6491.
69. Widnell, K.L., Russell, D.S., Nestler, E.J., 1994. Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc. Natl. Acad. Sci. U. S. A. 91, 10947-10951.
70. Winzer-Serhan, U.H., Chen, Y., Leslie, F.M., 2003. Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development. J. Chem. Neuroanat. 26, 17-36.
71. Wise, R.A., 2009. Roles for nigroestriatal-not just mesocorticolimbic- dopamine in reward and addiction. Trends Neurosci. 32, 517-524.